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Abstract
Background: Atrial tachycardia-induced remodeling promotes the occurrence and maintenance of atrial fibrillation (AF) and decreases
21 2L-type Ca current. There is also a clinical suggestion that acute L-type Ca channel blockade can promote AF, consistent with an AF
21 21promoting effect of Ca channel inhibition. Methods: To evaluate the potential mechanisms of AF promotion by Ca channel blockers,
we administered verapamil to morphine–chloralose anesthetized dogs. Diltiazem was used as a comparison drug and autonomic blockade
with atropine and nadolol was applied in some experiments. Epicardial mapping with 240 epicardial electrodes was used to evaluate
activation during AF. Results: Verapamil caused AF promotion in six dogs, increasing mean duration of AF induced by burst pacing,
from 864 s (mean6S.E.) to 95639 s (P,0.01 vs. control) at a loading dose of 0.1 mg/kg and 2286101 s (P,0.0005 vs. control) at a
dose of 0.2 mg/kg. Underlying electrophysiological mechanisms were studied in detail in five additional dogs under control conditions
and in the presence of the higher dose of verapamil. In these experiments, verapamil shortened mean effective refractory period (ERP)
from 12265 to 11464 ms (P,0.02) at a cycle length of 300 ms, decreased ERP heterogeneity (from 1561 to 1061%, P,0.05),
heterogeneously accelerated atrial conduction and decreased the cycle length of AF (9464 to 8463 ms, P,0.005). Diltiazem did not
affect ERP, AF cycle length or AF duration, but produced conduction acceleration similar to that caused by verapamil (n55). In the
presence of autonomic blockade, verapamil failed to promote AF and increased, rather than decreasing, refractoriness. Neither verapamil
nor diltiazem affected atrial conduction in the presence of autonomic blockade. Epicardial mapping suggested that verapamil promoted
AF by increasing the number of simultaneous wavefronts reflected by separate zones of reactivation in each cycle. Conclusions:
Verapamil promotes AF in normal dogs by promoting multiple circuit reentry, an effect dependent on intact autonomic tone and not
shared by diltiazem. Ó 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction prevent thromboembolic complications with oral antico-
agulants [3]. Among the drugs used to control the ventricu-
21Atrial fibrillation (AF) is presently the most common lar response rate are inhibitors of L-type Ca current such
sustained cardiac arrhythmia in clinical practice, and its as diltiazem and verapamil. There is, however, clinical
21treatment is less than optimal in many cases [1]. Antiar- evidence that Ca channel blockers such as verapamil and
rhythmic drugs improve sinus rhythm maintenance, but at diltiazem may promote AF maintenance [4]. Two recent
21the expense of a variety of potential adverse effects, of experimental studies also suggest that the Ca channel
which one of the most worrisome is ventricular proar- blocker verapamil may promote experimental AF. Lee et
rhythmia [2]. An alternative approach is to leave patients al. showed that verapamil administration during a 7–42
in AF, but to control the ventricular response and to day period of atrial tachycardia and at the time of a
subsequent electrophysiological study fails to prevent
tachycardia-induced remodeling and promotes AF mainte-
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nance during the electrophysiological study [5]. Friedman
et al. showed that verapamil promotes AF maintenance in
anesthetized dogs, an effect that can be prevented by
b-adrenoceptor blockade [6]. Neither study evaluated the
electrophysiological mechanisms potentially underlying
verapamil’s apparent AF promoting action. The present
study was designed to (1) determine whether verapamil
increases AF duration in the anesthetized dog in a dose
related fashion; (2) evaluate potential underlying mecha-
nisms by measuring atrial effective refractory period
(ERP) and conduction velocity, as well as by studying
changes in activation during AF with the use of atrial
21
epicardial mapping; and (3) determine whether the Ca
channel blocker diltiazem shares verapamil’s AF promot-
ing potential.
Fig. 1. Schematic of electrode arrays and bipolar electrode sites (dots).2. Methods
Stimulation sites for conduction measurements are indicated by haloed
dots. Arrows indicate the series of electrodes used for conduction velocity2.1. Animal preparation
analysis in each zone. AVR, atrio-ventricular ring; RFW, right free wall;
IVC, SVC, inferior, superior vena cava; PV, pulmonary vein; LPW, left
Twenty-five mongrel dogs (2761 kg) were studied in posterior wall.
four groups: (1) Group 1: a dose–response group (n56), in
which the effects of verapamil on AF duration were
studied at two dose levels (0.1 and 0.2 mg/kg loading previously described in detail [7,8]. A mapping system was
doses, followed by maintenance infusions of 0.5 and 1.5 connected to five arrays covering the atrial epicardial
mg/kg/min infusions, respectively); (2) Group 2: a de- surfaces with 240 bipolar electrodes (Fig. 1) as previously
tailed electrophysiology group (n55), in which the electro- described. Signals were filtered (bandwidth of 10–900 Hz),
physiological effects of verapamil were studied at a single, digitized (12-bit resolution and 2-kHz sampling rate), and
high loading dose (0.2 mg/kg, followed by 1.5 mg/kg/ transmitted into a Silicon Graphics computer for analysis.
min); (3) Group 3: a diltiazem group (n55), in which the Activation data were analyzed off line with computer
effects of diltiazem (0.8 mg/kg, followed by 15 mg/kg/ determined peak-amplitude criteria for activation, and data
min) were studied; and (4) Group 4: an autonomic for each electrode were reviewed manually. Atrial ERP
blockade group, in which the effects of verapamil (n55) (longest coupling interval at which premature electrical
and diltiazem (n54) were studied in the presence of extrastimuli failed to capture) and conduction velocity
pharmacological blockade of cardiac b-adrenergic and were measured during stimulation at sites in various atrial
muscarinic cholinergic receptors. regions as in previous work [7,8]. Activation maps for
Animal handling procedures followed the guidelines of conduction measurement were obtained after 60 s at a
the Canadian Council on Animal Care, and were approved variety of basic cycle lengths. Conduction velocity was
by the institutional animal research ethics committee. On measured with the use of two parallel sets of four
the study day, dogs were anesthetized with morphine (2 electrodes during local pacing in each of four regions: the
mg/kg s.c.) and a-chloralose (120 mg/kg i.v. load, 29.3 left atrial appendage, the right atrial appendage, the right
21
mg/kg h ) and ventilated to maintain physiological superior free wall and the right inferior free wall (Fig. 1).
arterial blood gases (pH 7.38–7.45, SaO .90%). Body Because of variable contact in the left atrium, complete2
temperature was maintained at 378C and a femoral artery conduction data were only available at right atrial sites. To
and both femoral veins were cannulated for arterial blood measure ERP, a 15 stimulus basic train (2-ms twice
pressure monitoring and drug administration. A median threshold current pulses) was followed by a premature
sternotomy was performed and bipolar PTFE coated extrastimulus at a progressively increasing coupling inter-
stainless electrodes hooked into right and left atrial appen- val and a 2-s pause to observe the response between trains.
dages for stimulation and recording. The surface ECG was The premature coupling interval was increased by 10-ms
monitored and epicardial mapping arrays sewn to the increments to obtain an initial estimate of the ERP. The
epicardial surfaces of both atria. measurement was then repeated with 5-ms increments and
the resulting value taken as the ERP. In the case of a
2.2. Electrophysiological study .10-ms difference between the two measurements, a third
measurement with 5-ms steps was obtained and the mean
The study preparation and instrumentation were as of all three ERP values was used. This protocol was used
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to measure ERPs at cycle lengths of 150, 200, 250, 300 2.4. Data analysis
and 350 ms at the right atrial appendage, and to measure
ERPs during stimulation at a single pacing cycle length The conduction velocity was determined in each region
(300 ms) at 2362 right and left atrial sites. as previously described. The coefficient of variance in ERP
AF was induced by stimulating the right atrial appen- was calculated as S.D. /mean3100% and used as an index
dage with 10 Hz, 2 ms stimuli at four times threshold of ERP heterogeneity. The number of sites for ERP
current for 2–10 s. To calculate mean AF duration, AF determination in each region was equivalent across dogs
was induced with burst pacing ten times for AF duration and between groups, to prevent any selection bias. Statisti-
,10 min and twice for AF duration .10 min. AF that cal comparisons between two groups only were performed
lasted .20 min, requiring electrical cardioversion for by Student’s t test. Analysis of variance with a range test
termination, was considered persistent. A 20-min rest was used for multiple group comparisons. Average results
period was allowed before continuing the experiment. are given as the mean6S.E.M., and a two-tailed P,0.05
was considered statistically significant.
2.3. Pharmacological study
3. Results
Verapamil and diltiazem were dissolved in 0.9% saline
the day of the experiment and were kept at 48C until 15 3.1. Dose related effects of verapamil
min before use. In the first part of the study (Group 1), we
tested two intravenous doses of verapamil hydrochloride The dose related effects of verapamil observed in Group
(Sigma): first dose: a loading infusion of 0.10 mg/kg over 1 dogs are summarized in Table 1. Verapamil slightly, but
10 min, followed by a maintenance dose of 0.5 mg/kg/min non-significantly, increased sinus cycle length, while caus-
for the time needed to complete electrophysiological ing clear, dose related decreases in arterial pressure. The
measurements (|30–45 min); second dose: load of 0.20 PR interval was also increased by the drug, with other
mg/kg, i.v.) followed by a maintenance infusion of 1.5 ECG intervals unaffected. AF duration was clearly in-
mg/kg/min. In each case, measurements were begun 10 creased in a dose related fashion.
min after the completion of the loading dose. These doses
were based on previously published data showing signifi- 3.2. Electrophysiological mechanisms of AF promotion
cant and stable pharmacological actions and plasma con- by verapamil
centrations [9]. We then pursued more detailed electro-
physiological evaluations with the higher dose only (Group In order to assess the mechanism by which verapamil
2 dogs). We then studied a group of dogs receiving promotes AF, we performed epicardial mapping during AF
diltiazem (Sigma) at the highest dose shown in a previous under control conditions and in the presence of the higher
multiple dose study [9] to be tolerated and produce stable dose of verapamil (Group 2 dogs). The general effects of
electrophysiological effects in the dog (loading dose 0.8 verapamil in Group 2 dogs are shown in Table 2. As in
mg/kg, followed by 15 mg/kg/min maintenance infusion). Group 1 dogs, 0.2 mg/kg verapamil slightly (but nonsig-
In a final group (Group 4), the effects of the higher dose of nificantly) prolonged sinus cycle length, reduced arterial
verapamil and of diltiazem were studied in the presence of pressure, and significantly increased both PR interval and
autonomic blockade produced with nadolol (0.5 mg/kg, AF duration. The results of mapping studies are illustrated
followed by an additional 0.25 mg/kg every 2 h) and in Fig. 2, which shows activation during three consecutive
atropine (1 mg every 2 h). cycles under control conditions (Fig. 2A) and in the
Table 1
aDose–response effects of verapamil (Group 1 dogs)
Control Verapamil Verapamil P
c c(lower dose) (higher dose)
b
n 6 6 6
Sinus CL (ms) 39365 424646 472645 0.480
Mean arterial BP (mmHg) 10469 8669 7668 0.0004
PR interval (ms) 10566 124611 158612 0.006
QRS duration (ms) 4362 4362 4361 0.990
QTc interval 30264 29369 28567 0.260
AF duration (s) 864 95639 2286101 0.0056
a Values are mean6S.E.M. CL, cycle length; BP, blood pressure; AF, atrial fibrillation; NS, not significant.
b Each dog was studied under both control and all drug conditions.
c Lower dose, 0.1 mg/kg loading dose followed by 0.5 mg/kg/min; Higher dose, 0.2 mg/kg loading dose followed by 1.5 mg/kg/min.
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Table 2
Comparison between effects of verapamil (Group 2 dogs) and diltiazem (Group 3)
Control Verapamil P Control Diltiazem P
(0.2 mg/kg, followed (0.8 mg/kg, followed
by 1.5 mg/kg/min) by 15 mg/kg/min)
a a
n 5 5 – 5 5 –
Sinus CL (ms) 373621 451641 0.113 376631 393611 0.656
Mean arterial BP (mmHg) 10169 8667 0.0081 8969 69611 0.025
PR interval (ms) 9264 12864 0.00014 9264 164621 0.0101
AF duration (s) 562 3996351 0.043 865 26615 0.318
a Each dog was studied under control and all drug conditions.
Fig. 2. Activation maps during three consecutive cycles of AF under control conditions (A), in the presence of verapamil, 0.2 mg/kg followed by 1.5
mg/kg/min (B) and in the presence of the same dose of verapamil and autonomic blockade (C). Lines are 20-ms isochrones, arrows are zones of wavefront
propagation during a cycle, dashed arrows are possible propagation to reactivate atrial tissue at the beginning of the next cycle and asterisks are zones of
reactivation at the beginning of the cycle. Under control conditions, only one or two zones of reactivation are seen per cycle, whereas in the presence of
verapamil (autonomic transmission intact) multiple reactivation zones occur (four per cycle in the example shown) and the activation pattern is clearly
more complex. In the presence of autonomic blockade, activation patterns in the presence of verapamil resemble those under control conditions.
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presence of verapamil (Fig. 2B). Isochrone maps (20-ms)
are shown, with the activation times indicated all refer-
enced to the earliest activation in the first cycle. Solid
arrows represent the direction of impulse propagation and
solid lines, zones of functional block (.40 ms activation
time differences between adjacent electrodes). Regions that
are not activated within a cycle are designated by 3s. The
dashed lines indicate probable paths of reactivation initiat-
ing the next cycle. Under control conditions (Fig. 2A),
activation is relatively homogeneous, with approximately
two discrete zones of reactivation (indicated by the aster-
isks) per cycle. In the presence of verapamil, activation is
more heterogeneous. There are more zones of functional
block, more apparent reentry circuits and more zones of
reactivation at the beginning of each cycle. Fig. 3A shows
mean data for the number of reactivation zones per cycle,
based on measurements for three consecutive cycles under
each condition in each dog. Verapamil clearly increased the
number of reactivation zones considerably, from just over
one to almost three /cycle. Thus, verapamil’s ability to
promote AF is likely related to the promotion of multiple
wavelet reentry by decreasing the size and increasing the
number of functional reentry circuits during the arrhyth-
mia.
In order to explore further the electrophysiological
mechanisms underlying verapamil’s AF promoting action,
we assessed drug-induced changes in atrial refractoriness
and conduction properties. ERP at the right atrial appendix
is shown as a function of cycle length in Fig. 4A.
Verapamil tended to decrease ERP slightly but not sig-
nificantly at long cycle lengths, with no change at short
cycle lengths. Fig. 4B shows mean ERP data from all sites
at a cycle length of 300 ms, and indicates that verapamil
slightly but significantly decreased ERP.Verapamil-induced
changes in AF cycle length are shown in Fig. 4C, which
indicates that the drug significantly decreased the mean
cycle length during AF, consistent with the ERP changes.
Fig. 4. Effects of verapamil (0.2 mg/kg followed by 1.5 mg/kg/min) inThe drug’s effects on ERP at a cycle length of 300 ms are the presence of intact autonomic tone on (A) ERP in the right atrial
further analyzed in Fig. 5. Verapamil did not alter sig- appendage; (B) mean ERP at all sites tested; and (C) AF cycle length.
Fig. 3. Effects of verapamil (0.2 mg/kg followed by 1.5 mg/kg/min) on the number of reactivation zones calculated on the basis of activation maps during
AF in the absence (A) or presence (B) of autonomic blockade.
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ERP and conduction, mean reentrant wavelength was
unaffected by the drug (11.060.6 cm before and 11.360.5
cm after verapamil administration).
3.3. Effects of diltiazem on atrial electrophysiology
and AF
To determine whether diltiazem shares verapamil’s
actions on atrial electrophysiology and arrhythmias, we
studied the effects of the drug in Group 3 dogs. Like high
dose verapamil, diltiazem decreased arterial pressure and
increased the PR interval (Table 2). Unlike verapamil,
diltiazem did not significantly alter AF duration. Diltiazem
did not alter atrial ERP, which averaged 11262 ms at all
sites (cycle length 300 ms) before diltiazem and 11663 ms
after the drug. Similarly, AF cycle length was not affected
by diltiazem (9463 ms control, 9263 ms drug, P5NS).
Diltiazem did produce significant increases in conduction
velocity, with a spatial distribution similar to those caused
by verapamil (Fig. 6, right). Thus, despite similar effects
on blood pressure, PR interval and intra-atrial conduction,
diltiazem did not share verapamil’s ability to decrease
atrial ERP or AF cycle length and did not promote AF.
3.4. Effects of verapamil and diltiazem in the presence
of autonomic blockade
In order to evaluate effects of verapamil and diltiazem in
the absence of autonomic reflexes, we studied Group 4
dogs in the presence of b-adrenergic and muscarinic
receptor blockade. In the presence of autonomic blockade,
verapamil reduced arterial pressure and increased the PR
interval, but did not affect AF duration (Table 3, Fig. 7A).
Typical activation maps for AF in the presence of ver-
apamil and autonomic blockade are shown in Fig. 2C, and
indicate that under these conditions activation was rela-
tively homogeneous and there were few reactivation zonesFig. 5. Effects of verapamil (0.2 mg/kg followed by 1.5 mg/kg/min) in
the presence of intact autonomic tone on (A) minimal ERP value at a per cycle. A quantitative analysis is shown in Fig. 3B, and
cycle length of 300 ms in each dog; (B) maximal ERP in each dog; and indicates that in the presence of autonomic blockade(C) ERP heterogeneity calculated for each condition in each dog as the
verapamil did not alter the number of reactivation zones
standard deviation of all ERP values divided by the mean ERP value
per cycle of AF. In contrast to its effects in the presence oftimes 100%.
intact autonomic reflexes, verapamil significantly increased
AF cycle length in the presence of autonomic blockade
nificantly the shortest ERP value for all sites in each dog (Fig. 7B) and slightly but significantly increased ERP (Fig.
(Fig. 5A), but substantially decreased the maximum value 7C) without affecting ERP heterogeneity (Fig. 7D). Unlike
(Fig. 5B). Since verapamil decreased longer ERP values the effects of both verapamil and diltiazem in the presence
without significantly affecting short ERPs, the drug sig- of intact autonomic reflexes, conduction velocity was
nificantly reduced ERP heterogeneity (Fig. 5C). unaffected by verapamil administration in the presence of
Verapamil produced spatially variable changes in con- autonomic blockade (Fig. 8left). These results indicate an
duction. The drug resulted in faster conduction in the right important role for autonomic reflexes in mediating the
atrial superior and posterior free walls, but did not change electrophysiological changes observed after verapamil
conduction speed in the right atrial appendage (Fig. 6left). administration. Diltiazem produced qualitatively similar
When all observations in the right atrium were combined, changes to verapamil in sinus cycle length, arterial pres-
verapamil reduced ERP from 12265 to 11464 ms and sure and PR interval in the presence of autonomic bloc-
increased conduction velocity from 9062 to 9963 cm/s kade (Table 3), and similarly failed to alter AF duration.
(P,0.02 for each). Because of the offsetting changes in Changes in conduction velocity after diltiazem administra-
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Fig. 6. Effect of verapamil (0.2 mg/kg followed by 1.5 mg/kg/min, left panels) and diltiazem (0.8 mg/kg followed by 15 mg/kg/min, right panels) in the
presence of intact autonomic tone on conduction velocity in each of three atrial regions.
tion in the presence of autonomic blockade are shown in 4. Discussion
Fig. 8 (right panels). As for verapamil, no significant
changes in conduction were seen after diltiazem adminis- We have shown that verapamil promotes the mainte-
tration when the experiment was conducted in the presence nance of AF in normal dogs. The underlying mechanism
of b-adrenergic and muscarinic blockade. appears to be a potentiation of multiple circuit reentry
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Table 3
Comparison between effects of verapamil and diltiazem in presence of autonomic blockade (Group 4)
Control Verapamil P Control Diltiazem P
(0.2 mg/kg, followed (0.8 mg/kg, followed
by 1.5 mg/kg/min) by 15 mg/kg/min)
a a
n 5 5 – 4 4 –
Sinus CL (ms) 448640 590646 0.048 585657 750623 0.113
Mean arterial BP (mmHg) 9268 68610 0.048 9163 6064 0.041
PR interval (ms) 10868 149615 0.011 11568 156622 0.123
AF duration (s) 1766 1567 0.80 65632 33616 0.54
a Each dog was studied under continuous autonomic blockade for both control and drug conditions.
requiring intact autonomic function. Diltiazem did not dependent ERP adaptation being hallmark features [12].
21
share the AF promoting action of verapamil in this model. Decreases in L-type Ca current seem to be central to
these electrophysiological effects of tachycardia-induced
21 214.1. Role of L-type Ca currents and their blockade remodeling [13]. Ca overload due to an increased rate of
in AF action potential generation may be important in initiating
tachycardia-related remodeling, which may in part be a
21L-type Ca current plays an important role in maintain- protective response of cardiomyocytes to prevent damage
21ing the plateau of the atrial action potential and changes in caused by Ca loading [14]. Consistent with this concept,
21Ca current are an important contributor to rate-depen- verapamil prevents some of the changes caused by short
dent adaptations in atrial action potential duration [10,11]. term (,24 h) atrial tachycardias [15–18]; however, L-type
21Atrial tachycardias, including AF, modify atrial properties Ca channel blockers do not prevent remodeling by atrial
to promote AF maintenance, with reduced ERP and rate- tachycardias lasting a week or longer [5,19]. Furthermore,
Fig. 7. Effects of verapamil (0.2 mg/kg followed by 1.5 mg/kg/min) in the presence of autonomic blockade on (A) AF duration; (B) AF cycle length; (C)
mean ERP at all atrial sites; and (D) ERP heterogeneity.
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Fig. 8. Effect of verapamil (0.2 mg/kg followed by 1.5 mg/kg/min, left panels) and diltiazem (0.8 mg/kg followed by 15 mg/kg/min, right panels) in the
presence of autonomic blockade on conduction velocity in each of three atrial regions.
dogs maintained on verapamil up to and during electro- changes caused by atrial tachycardia-induced remodeling
21physiological study after a 7-day or greater period of atrial [13], it would not be surprising for Ca channel blockers
tachycardia have more sustained AF than control dogs [5]. like verapamil to promote AF maintenance. The results of
21Given the fact that reduced Ca current seems to be the present study do show that verapamil promotes AF;
important in the AF-promoting atrial action potential however, a number of our findings argue against the simple
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notion that this action of verapamil is due to a mimicking AF. Alternatively, verapamil’s actions on atrial activation
of the changes caused by atrial tachycardia. First, atrial during AF may have resulted from presently unrecognized
tachycardia-induced remodeling causes substantial de- actions on impulse propagation during the arrhythmia, or
creases in atrial ERP [12,13], whereas the decreases caused from other at present unrecognized actions.
by verapamil in the present paper were relatively modest. Verapamil has also been noted to have effects on
Second, increased atrial ERP heterogeneity is a prominent ventricular fibrillation (VF). In isolated hearts, which by
AF-promoting feature of tachycardia-induced remodeling definition lack reflex autonomic responses, verapamil
in the dog [20,21], whereas ERP heterogeneity was decreases the complexity of fibrillatory activity [24,25]. On
reduced by verapamil. Third, if verapamil’s AF-promoting the other hand, verapamil increases the frequency of
21
effects were due to L-type Ca channel blockade alone, ventricular fibrillatory activity in the in situ heart [26].
one would have expected them to be enhanced by b- These results are consistent with AF activation changes
21
adrenergic blockade, since the latter reduces L-type Ca seen respectively in the absence and presence of autonomic
current; however, the opposite result (an elimination of AF blockade in the present study. They suggest that ver-
promotion) was seen in autonomically blocked dogs. apamil’s effects on AF and VF have some interesting
21Finally, if Ca channel blockade was the primary mecha- similarities, which warrant more detailed analysis in
nism of verapamil’s AF-promoting properties, one might subsequent work.
have expected to have observed similar phenomena with Although intact autonomic reflexes were required for
diltiazem, particularly at doses (like the ones we used) that verapamil’s AF-promoting actions, consistent with previ-
cause comparable degrees of PR interval prolongation. ous observations [6], autonomic interactions alone were
insufficient to explain the effects of verapamil. Vagal
4.2. Mechanism of verapamil’s AF promoting properties enhancement is unlikely to have played any significant
role, since increasing vagal tone substantially increases
Verapamil promoted AF in the present study by increas- atrial ERP heterogeneity [27], the opposite of the changes
ing the apparent number of reentry circuits during AF and seen with verapamil. Friedman et al. showed that the
thereby stabilizing multiple circuit reentry. Precisely how AF-promoting effects of verapamil are prevented by b-
verapamil achieved this remains unclear. Although ver- adrenergic receptor blockade, pointing to an important role
apamil did decrease atrial ERP, this effect was relatively for sympathetic stimulation [6]. Sympathetic enhancement
small during 1:1 atrial pacing, and seems insufficient to is likely to have occurred during verapamil infusion, but
explain the significant changes in atrial activation that increased sympathetic outflow itself has not been found to
occurred during AF. Furthermore, verapamil accelerated have a significant AF-promoting effect in the normal dog
conduction in several atrial regions, which counteracts the heart [27]. It is therefore likely that intact sympathetic
effect of ERP reductions on wavelength, leaving the responses are necessary for verapamil’s AF-promoting
minimal reentrant circuit size apparently unchanged. It is action, but that in themselves sympathetic effects are
possible that the regional variability of the conduction insufficient to account fully for this property of the drug.
speeding effect of verapamil contributed to heterogeneous The discrepancy between verapamil and diltiazem in
activation during AF; however, this is unlikely to have AF-promoting properties is an interesting observation that
been of prime importance, since diltiazem had similar requires explanation. Unlike verapamil, diltiazem did not
effects on atrial conduction but did not promote AF. The decrease ERP or AF cycle length. Of note, diltiazem’s
abolition of conduction-speeding by both drugs with effects on atrial conduction were very similar to those of
autonomic blockade suggests that this action was indirect, verapamil in both the presence and absence of autonomic
quite possibly due to adrenergic enhancement. tone (Figs. 6 and 8). Diltiazem’s lack of AF-promoting
We measured atrial ERP and conduction velocity during potential could be due to a different time and voltage
211:1 atrial pacing, and it is possible that these do not dependent profile of Ca channel blockade or to different
necessarily reflect the drug’s electrophysiological actions collateral properties. Further studies to clarify this issue, in
at the very rapid rates of AF. Verapamil has complex both experimental and clinical settings, might be of
1
effects on a variety of K channels [22], as well as rate considerable interest.
21
and voltage dependent blocking actions on L-type Ca
1
channels [23]. The K -channel inhibiting actions of the 4.3. Novel aspects and potential clinical relevance
drug may explain its effect to prolong ERP in the present
study when adrenergic reflexes were absent in au- Verapamil’s AF promoting action has been reported
tonomically-blocked dogs. The rate dependent effects of clinically [4] and in an experimental model [6]. Neither
1 21
verapamil on various K and Ca channels, the varying publication addressed potential underlying electrophysio-
importance of each channel during the action potential logical mechanisms. Friedman et al. did show that beta-
plateau at different rates, and varying degrees of adrenergic adrenoceptor blockade prevents AF promotion by ver-
reflex activity at different heart rates may have resulted in apamil, but did not examine electrophysiological changes.
much smaller ERP changes at slower 1:1 rates than during In the present study, we show that verapamil promotes AF
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[3] Reiffel JA. Drug choices in the treatment of atrial fibrillation. Am Jby increasing the heterogeneity of activation and the
Cardiol 2000;85(Suppl 1):12–19.number of apparent reentry zones during the arrhythmia. [4] Shenasa M, Kus T, Fromer M et al. Effect of intravenous and oralThis observation is consistent with the multiple wavelet
calcium antagonists (diltiazem and verapamil) on sustenance of
mechanism of AF maintenance [28]. On the other hand, atrial fibrillation. Am J Cardiol 1988;62:403–407.
despite obtaining careful measurements of properties (like [5] Lee SH, Yu WC, Cheng JJ et al. Effect of verapamil on long-term
tachycardia-induced atrial electrical remodeling. CirculationERP and ERP heterogeneity) usually associated with the
2000;101:200–206.stability of multiple circuit reentry, the precise electro-
[6] Friedman HS, Rodney E, Sinha B et al. Verapamil prolongs atrialphysiological mechanism by which multiple wavelet reen- fibrillation by evoking an intense sympathetic neurohumoral effect. J
try was promoted remains obscure. It is possible that Investig Med 1999;47:293–303.
21changes in ERP, ERP heterogeneity, conduction velocity [7] Fareh S, Benardeau A, Thibault B et al. The T-type Ca channel
blocker mibefradil prevents the development of a substrate for atrialand wavelength during 1:1 pacing do not, in the presence
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